Stay updated on Pegcetacoplan in C3 Glomerulopathy: Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.

Latest updates to the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page has been updated with new dates and figures, including a completed status and specific dates in March 2025, while previous dates and estimates have been removed.SummaryDifference1%
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe webpage has removed a notice regarding heavy traffic affecting certain NLM-NCBI services and products, as well as a link to helpful resources provided by Apellis Pharmaceuticals, Inc.SummaryDifference1%
- Check45 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check53 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check60 days agoChange DetectedA new section titled 'Helpful Links Provided by Apellis Pharmaceuticals, Inc. Study Website' has been added to the website.SummaryDifference0.3%
- Check67 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
Stay in the know with updates to Pegcetacoplan in C3 Glomerulopathy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.